Skip to main content
Article
Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study
BMC Infectious Diseases (2016)
  • Isaac Zentner, Drexel University
  • Hans P. Schlecht, Drexel University
  • Lorna Khensouvann, Genomind, Inc, King of Prussia, USA
  • Neo Tamuhla, University of Pennsylvania
  • Michele Kutzler, Drexel University
  • Vijay Ivaturi, University of Maryland, Baltimore
  • Jotam G. Pasipanodya, Center for Infectious Disease Research and Policy
  • Tawanda Gumbo, Center for Infectious Disease Research and Policy
  • Charles A. Peloquin, University of Florida
  • Gregory P. Bisson, University of Pennsylvania
  • Christopher Vinnard, Public Health Research Institute
Publication Date
December 1, 2016
DOI
10.1186/s12879-016-1576-1
Citation Information
Isaac Zentner, Hans P. Schlecht, Lorna Khensouvann, Neo Tamuhla, et al.. "Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study" BMC Infectious Diseases Vol. 16 Iss. 1 (2016) p. 242
Available at: http://works.bepress.com/hans-schlecht/4/